Abstract

Objectives: Infusion of angiotensin II (AngII) into apoE -/- mice results in abdominal aortic aneurysms (AAA) that exhibit features of human AAA, including medial degradation, inflammation, and rupture. We determined that apoE -/- mice deficient in acute phase serum amyloid A (SAA) are protected from AngII-induced AAA (unpublished data). SAA is thought to orchestrate the inflammatory response to tissue injury by stimulating cytokine induction, inflammatory cell recruitment, and extracellular matrix turnover. In this study we performed in vitro and in vivo studies to test the hypothesis that SAA promotes AAA by augmenting inflammation and matrix degradation in abdominal aortas of AngII-infused mice. Methods and Results: Male apoE -/- mice were infused with 1000 ng/kg/min AngII or saline for 10 days. Abdominal aortas, defined as the 10.4mm region of the aorta immediately above the right superior renal vessel, were analyzed in vivo using a 7T ClinScan MRI and ex vivo by immunohistochemistry and in situ zymography. Vessel wall distensibility was markedly lower in the AngII-infused mouse abdominal aorta (0.54%/mm Hg) compared to saline control (1.07%/mm Hg). Sections of AAA corresponding to regions of lowest distensibility were distinguished by breaks in the elastin lamina that co-localized with intense matrix metalloproteinase (MMP) activity and prominent macrophage and SAA immunoreactivity. In more distensible regions of AAA, there was no evidence of elastin breaks, and MMP activity and macrophage and SAA immunoreactivity were less pronounced. Primary mouse aortic smooth muscle cells (VSMC) were cultured for 3 days and then treated for 8 hours in the presence or absence of 50μg/ml purified mouse SAA. Results from RT-PCR arrays indicated that SAA altered the expression of genes involved in inflammation (52 out 84 analyzed) and extracellular matrix/cell adhesion (24 out of 84 analyzed). Conventional RT-PCR confirmed that SAA induces the expression of Ccl2, MMP9 and MMP13 in mouse aortic VSMCs. Conclusions: SAA stimulates chemokine and MMP expression in VSMC that may lead to macrophage infiltration, medial degradation, and decreased arterial distensibility in AngII-induced AAA. SAA is potentially a useful biomarker and therapeutic target for human AAA.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.